NL-OMON37985已完成4 期
The effect of fibrate therapy in two patients with neutral lipid storage disease with myopathy (NLSDM). - Fibrate Trail
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- Patients with NLSDM;Controls:
- •- female gender
- •- between 20-45 years old
- •- BMI between 20-30 kg/m2
- •- healthy (no chronic diseases)
排除标准
- •- none;Controls:
- •- use of Fibrates and anti-coagulantia
- •- Contra-indications for MRI:
- •- Electronic implants such as pacemakers or neurostimulator
- •- Iron-containing corpora aliena in eyes or brain
- •- Some hearing aids and artificial (heart) valves which are contraindicated for MRS
- •- Claustrophobia
- •- Subjects, who do not want to be informed about unexpected medical findings, or do not wish that their physician is informed, cannot participate in the study.
研究者
相似试验
进行中(未招募)
不适用
The effect of lipid lowering medication on lipid accumulation in patients with neutral lipid storage disease with muscle weakness.eutral lipid storage disease with myopathyMedDRA version: 13.1Level: PTClassification code 10007636Term: CardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 13.1Level: HLGTClassification code 10013317Term: Lipid metabolism disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 13.1Level: PTClassification code 10028641Term: MyopathySystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-001205-27-NL
已完成
不适用
Additional treatment with fibrates for patients treated with pitavastatin under ordinary medical practice for hypertriglyceridemia in JapaCombined dyslipidemiaJPRN-UMIN000001828Chu-NET60
已完成
不适用
Comparison of therapeutic effects of Fenofibrate and Gemfibrozil on Lipid in patients with DiabetesIRCT201401096710N4Research deputy of Tabriz University of Medical Sciences60
已完成
3 期
Evaluation of efficacy and safety of Fenofibrate in COVID-19 patientsIRCT20220612055149N1Artesh University of Medical Sciences70
招募中
不适用
Anti-fibrotic treatment in patients with idiopathic pulmonary fibrosis:A cohort studyidiopathic pulmonary fibrosisJPRN-UMIN000020392niversity of Occupational and Environmental Health, Japan100
